Improving PrEP Access for HIV Prevention in Primary Care
A Multilevel, Multiphase Optimization Strategy for PrEP: Patients and Providers in Primary Care
This project aims to find the best ways for primary care doctors to offer HIV prevention medication (PrEP) to more patients, especially those who currently receive it less often.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Henry Ford Health + Michigan State University Health Sciences NIH-funded |
| Lab location | 1 site (East Lansing, United States) |
| Project ID | NIH-11061415 on NIH RePORTER |
What this research studies
Many people who could benefit from PrEP, a medication that prevents HIV, are not currently receiving it, particularly Black and Latino individuals. This project will work with primary care clinics at Henry Ford Health to discover the most effective ways to make PrEP available to more patients. We will gather feedback from both patients and healthcare providers to understand what works best. Then, we will test different combinations of approaches to see which ones lead to more new PrEP prescriptions. Finally, we will collect more feedback to understand how these new methods were put into practice.
Who could benefit from this research
Good fit: Ideal candidates are patients who are eligible for PrEP and receive care within the Henry Ford Health system, particularly those from Black and Latino communities.
Not a fit: Patients who are not at risk for HIV or are not seeking HIV prevention methods would not directly benefit from this specific project.
Why it matters
Potential benefit: If successful, this work could significantly increase the number of people who receive life-saving HIV prevention medication, especially in communities where it is currently underused.
How similar studies have performed: This project uses a novel and innovative framework called MOST to identify efficient interventions, building on the understanding that disparities in PrEP uptake exist.
Where this research is happening
East Lansing, United States
- Henry Ford Health + Michigan State University Health Sciences — East Lansing, United States (Active)
Researchers
- Principal investigator: Lockhart, Elizabeth — Henry Ford Health + Michigan State University Health Sciences
- Study coordinator: Lockhart, Elizabeth
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.